These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 4598115)

  • 1. Effects of exogenous estrogen and progestin on pituitary responsiveness to synthetic luteinizing hormone-releasing factor.
    Vandenberg G; DeVane G; Yen SS
    J Clin Invest; 1974 Jun; 53(6):1750-4. PubMed ID: 4598115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct evidence of estrogen modulation of pituitary sensitivity to luteinizing hormone-releasing factor during the menstrual cycle.
    Wang CF; Yen SS
    J Clin Invest; 1975 Jan; 55(1):201-4. PubMed ID: 1088908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary gonadotrophin responsiveness to synthetic LRF in subjects with normal and abnormal hypothalamic-pituitary-gonadal axis.
    Yen SS; Rebar R; Vandenberg G; Ehara Y; Siler T
    J Reprod Fertil Suppl; 1973 Dec; 20(0):137-61. PubMed ID: 4599401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
    Lasley BL; Wang CF; Yen SS
    J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
    Scott JA; Brenner PF; Kletzky OA; Mishell DR
    Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of estrogen in the modulation of pituitary sensitivity of LRF (luteinizing hormone-releasing factor) in men.
    Wang CF; Lasley BL; Yen SS
    J Clin Endocrinol Metab; 1975 Jul; 41(1):41-3. PubMed ID: 1097463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Interaction between gonadal steroids and LH-releasing hormone to control gonadotropin secretion at the pituitary level.
    Negro-Vilar A
    Acta Physiol Lat Am; 1973; 23(6):494-6. PubMed ID: 4604956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
    Scott JZ; Kletzky OA; Brenner PF; Mishell DR
    Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin responses following luteinizing hormone releasing hormone administration in normal subjects.
    Wentz AC; Jones GS; Rocco L
    Obstet Gynecol; 1975 Mar; 45(3):239-46. PubMed ID: 1089927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary and ovarian response to luteinizing hormone releasing factor in normal and sulpiride-induced hyperprolactinemic women.
    Yagi S; Nakano R
    Obstet Gynecol; 1982 Nov; 60(5):571-6. PubMed ID: 6815597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oral contraceptives on the gonadotropin response to LHRH.
    Rubinstein L; Moguilevsky J; Leiderman S
    Obstet Gynecol; 1978 Nov; 52(5):571-4. PubMed ID: 364356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of gonadal steroids on the pituitary gonadotrophin response to luteinizing hormone releasing factor (LRF) in the rat.
    Nakano R; Kayashima F; Kotsuji F; Tojo S
    Endokrinologie; 1974 Mar; 63(1):147-54. PubMed ID: 4611760
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).
    Mortimer RH; Fleischer N; Lev-Gur M; Freeman RG
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphasic change in pituitary capacity induced by estrogen in hypogonadal women.
    Lachelin GC; Yen SS
    J Clin Endocrinol Metab; 1978 Mar; 46(3):369-73. PubMed ID: 109457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructure of rat pituitary gonadotrophs after injection of synthetic luteinizing hormone releasing factor (LRF).
    Nakano R; Lee W; Hayashi K; Tojo S
    Endokrinologie; 1975 Feb; 65(1):60-5. PubMed ID: 1100366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of pituitary responsiveness to LRF by estrogen.
    Yen SS; Vandenberg G; Siler TM
    J Clin Endocrinol Metab; 1974 Jul; 39(1):170-7. PubMed ID: 4600507
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the site of action of oral contraceptive steroids. II. Plasma LH and FSH levels after administration of antifertility steroids and LH-releasing hormone(LH-RH).
    Schally AV; Parlow AF; Carter WH; Saito M; Bowers CY; Arimura A
    Endocrinology; 1970 Mar; 86(3):530-41. PubMed ID: 4188612
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of synthetic sex steroids on the pituitary responsiveness to luteinizing hormone releasing hormone (LH-RH) (author's transl)].
    Higashiyama S; Iwasaki T; Kizu S; Okada H
    Nihon Naibunpi Gakkai Zasshi; 1976 Jan; 52(1):72-82. PubMed ID: 767171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.